Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Novel vitamin D analogues with utility in dermatological disorders designed at Galderma

July 8, 2003

Connetics submits NDA for Extina in seborrheic dermatitis

July 7, 2003

Liarozole granted E.U. orphan drug designation for congenital ichthyosis

July 4, 2003

Olux cleared for marketing in U.K.

July 3, 2003

Positive outcome for phase II study of Periostat as adjunctive treatment for rosacea

July 3, 2003

Phase II findings for onercept in psoriasis and psoriatic arthritis

June 30, 2003

Enbrel improves plaque psoriasis symptoms in phase III study

June 27, 2003

VIC-acne completes phase I safety study

June 25, 2003

Shiseido synthesizes new MMP inhibitors

June 23, 2003

Dompe patents novel inhibitors of IL-8 and GROalpha-induced chemotaxis

June 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...